Symptom trajectories and treatment outcomes following a five-day accelerated intermittent-theta burst stimulation protocol for treatment-resistant depression: A naturalistic study in a real-world setting
- 5 June 2026
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 364, 117264
Abstract
No abstract availableKeywords
Funding Information
- Neurocrine Biosciences
This publication has 33 references indexed in Scilit:
- Accelerated Theta-Burst Stimulation for Treatment-Resistant DepressionJAMA Psychiatry, 2025
- Four weeks standard vs. one week accelerated intermittent Theta Burst Stimulation for the treatment of depression – A retrospective analysisBehavioural Brain Research, 2024
- Accelerated intermittent theta burst stimulation for major depressive disorder or bipolar depression: A systematic review and meta-analysisAsian Journal of Psychiatry, 2023
- Can early treatment response serve as a predictor of antidepressant outcome of repetitive Transcranial Magnetic Stimulation?Brain Stimulation, 2020
- Early symptom improvement at 10 sessions as a predictor of rTMS treatment outcome in major depressionBrain Stimulation, 2018
- Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older AdultsJAMA Psychiatry, 2015
- Concordance Between BeamF3 and MRI-neuronavigated Target Sites for Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal CortexBrain Stimulation, 2015
- SELF-REPORT AND CLINICIAN-RATED MEASURES OF DEPRESSION SEVERITY: CAN ONE REPLACE THE OTHER?Depression and Anxiety, 2012
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Validation and Utility of a Self-report Version of PRIME-MDThe PHQ Primary Care StudyJAMA, 1999